A mutation in the extracellular cysteine-rich repeat region of the β3 subunit activates integrins α(IIb)β3 andα(v)β3

Blood

Volumn 93, Issue 8, 1999, Pages 2559-2568

  Kashiwagi, Hirokazu ^a   Tomiyama, Yoshiaki ^b   Tadokoro, Seiji ^b   Honda, Shigenori ^b   Shiraga, Masamichi ^b   Mizutani, Hajime ^b   Handa, Makoto ^b   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^b   Shattil, Sanford J ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; INTEGRIN; PROTEIN SUBUNIT;

AMINO ACID METABOLISM; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL DEATH; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE MUTATION; GLYCOSYLATION; HEMOSTASIS; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; THROMBOCYTE ACTIVATION;

EID: 0033561096     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2559     Document Type: Article

References (54)

1. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
2. Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5:864, 1993
3. 3 integrins in hemostasis and vascular biology. Thromb Haemost 74:149, 1995
4. Rabinowich H, Lin WC, Amoscato A, Herberman RB, Whiteside TL: Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. J Immunol 154:1124, 1995
5. Ginsberg MH, Du X, Plow EF: Inside-out integrin signaling. Curr Opin Cell Biol 4:766, 1992
6. Shattil SJ, Kashiwagi H, Pampori N: Integrin signaling: The platelet paradigm. Blood 91:2645, 1998
7. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 11:549, 1995
8. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
9. Fitzgerald LA, Steiner B, Rall SC Jr, Lo SS, Phillips DR: Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to 'integrin'. J Biol Chem 262:3936, 1987
10. 3 subunit. J Biol Chem 271:21978, 1996
11. Calvete JJ, Henschen A, Gonzalez-Rodriguez J: Assignment of disulphide bonds in human platelet GPIIIa: A disulphide pattern for the β-subunits of the integrin family. Biochem J 274:63, 1991
12. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 249:915, 1990
13. IIb. Science 254:845, 1991
14. 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem 267:3789, 1992
15. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 89:10169, 1992
16. 3 integrin. J Biol Chem 269:20913, 1994
17. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 124:1047, 1994
18. Hughes PE, Diaz-Gonzalez F, Leong L, Wu C, McDonald JA, Shattil SJ, Ginsberg MH: Breaking the integrin hinge: A defined structural constraint regulates integrin signaling. J Biol Chem 271:6571, 1996
19. Baker EK, Tozer EC, Pfaff M, Shattil SJ, Loftus JC, Ginsberg MH: A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro. Proc Natl Acad Sci USA 94:1973, 1997
20. 3(glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 266:17106, 1991
21. 3. J Biol Chem 268:23087, 1993
22. 3 subunit. J Biol Chem 270:11947, 1995
23. Shattil SJ, Hoxie JA, Cunningham M, Brass LF: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260:11107, 1985
24. 3. J Biol Chem 265:6346, 1990
25. Newman PJ, Allen RW, Kahn RA, Kunicki TJ: Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP3. Blood 65:227, 1985
26. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ: Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein GPIIb-IIIa complex, with intact platelet. J Biol Chem 258:12582, 1983
27. 3 integrin). Thromb Haemost 76: 1038, 1996
28. Cheresh DA: Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84:6471, 1987
29. 478C→T substitution (prorine90→serine) in CD36 cDNA account for CD36 deficiency. J Clin Invest 95:1040, 1995
30. 3 integrin cytoplasmic tail. J Cell Biol 137:1433, 1997
31. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y: Abnormal processing of the glycoprotein lib transcript due to a nonsense mutation in exon 17 associated with Glanzmann thrombasthenia. Thromb Haemost 73:756, 1995
32. 3 deficiency in Glanzmann thrombasthenia. Blood 92: 2750, 1998
33. Honda S, Tomiyama Y, Shiraga M, Tadokoro S, Takamatsu J, Saito H, Kurata Y, Matsuzawa Y: A two-amino acid insertion in the Cys146-Cys167 loop of the IIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding. J Clin Invest 102:1183, 1998
34. Aoki T, Cox D, Senzaki K, Seki J, Tanaka A, Takasugi H, Motoyama Y: The anti-platelet and anti-thrombotic effects of FK633, a peptide-minetic GPIIb/IIIa antagonist. Thromb Res 81:439, 1996
35. 2+ signaling. Blood 92: 3675, 1998
36. 3 integrin) confers fibrinogen-and activation-dependent aggregation on heterologous cells. Blood 78:369, 1991
37. Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ: Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation 89:1802, 1994
38. 1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 269:12325, 1994
39. Schaller MD, Parsons JT: Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 6:705, 1994
40. Clark EA, Shattil SJ, Brugge JS: Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci 19:464, 1994
41. 3 (platelet glycoprotein IIb-IIIa). J Biol Chem 267:22211, 1992
42. Liu CY, Sun QH, Wang R, Paddock CM, Newman PJ: Disruption of the long-range GPIIIa Cys5-Cys435 disulfide bond results in the production of a constitutively active GPIIb-IIIa integrin complex. Blood 90:573a, 1997 (abstr, suppl 1)
43. Zucker MB, Masiello NC: Platelet aggregation caused by dithiothreitol. Thromb Haemost 51:119, 1984
44. 3 subunit. J Biol Chem 269:8754, 1994
45. 3 integrins (GPIIIa) with their human counterpart. Biochem Biophys Res Commun 193:771, 1993
46. Bazzoni G, Hemler ME: Are changes in integrin affinity and conformation overemphasized? Trends Biochem Sci 23:30, 1998
47. 3. J Cell Biol 141:1685, 1998
48. FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem 269:14738, 1994
49. 3. EMBO J 16:6414, 1997
50. 3 involves a discrete cation-binding site that regulates conformation. J Biol Chem 271:1364, 1996
51. 3 integrin retains high affinity for ligand binding: Evidence for an 'inside-out' suppressor? Biochem J 330:861, 1998
52. Loftus JC, Liddington RC: Cell adhesion in vascular biology. New insights into integrin-ligand interaction. J Clin Invest 99:2302, 1997
53. 3-integrin subunit gene in avian osteoclast precursors. Endocrinology 134:1061, 1994
54. 6 subunits. Dev Biol 160:265, 1993